Cleared Special

K231176 - Stingray LP Catheter

K231176 is the FDA 510(k) clearance for Stingray LP Catheter by Boston Scientific. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 30-day FDA review.

K231176 · Boston Scientific · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
30d
Days
Class 2
Risk

K231176 is an FDA 510(k) clearance for the Stingray LP Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Boston Scientific (Maple Grove, US). The FDA issued a Cleared decision on May 25, 2023 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific devices

Submission Details

510(k) Number K231176 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2023
Decision Date May 25, 2023
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K231176.
Micro Rx
K223728 · Imds Operations B.V. · Jul 2023
5F Launcher Guide Catheter, 6F Launcher Guide Catheter, 7F Launcher Guide Catheter, 8F Launcher Guide Catheter
K230156 · Medtronic Vascular · Jun 2023
CPS Direct™ Universal slittable outer guide catheter (DS2C029)
K231311 · Abbott Medical · Jun 2023
RayFlow
K222023 · Hexacath · Apr 2023
CPS Locator 3D Delivery Catheter
K230363 · CenterPoint Systems, LLC · Mar 2023
6F Wallaby Long Sheath
K222603 · Wallaby Medical, Inc. · Mar 2023